GlaxoSmithKline is buying Human Genome Sciences for $3.6 billion, giving it full ownership of Benlysta, along with albiglutide and darapladib, after months of M&A intrigue. “We are pleased to have ...
New York, Aug. 26, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Benlysta (belimumab) - Drug Insight and Market Forecast - 2030 ...
GSK today announced results from BLISS-SC, a 52-week study for BENLYSTA (belimumab) for subcutaneous use (SC) in adult patients with active, autoantibody-positive systemic lupus erythematosus (SLE) ...
The Lupus Foundation of America works to improve the quality of life for all people affected by lupus through programs of research, education, support and advocacy. 2X Your Impact: Our Giving Tuesday ...
EXTON, Pa., Aug. 8, 2013 /PRNewswire/ -- BioTrends Research Group, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that rheumatologists in the ...
A new subcutaneous formulation of GlaxoSmithKline’s Benlysta has been approved as an add-on therapy for certain in adults with the autoimmune disease systemic lupus erythematosus (SLE). A new ...
GlaxoSmithKline hopes to get its new Benlysta formula under lupus patients’ skin—literally. The company won FDA approval last week for a subcutaneous version of the immunology med, previously ...
UPDATE: On May 8, the Lupus Foundation of America submitted comments on CMS' interim final rule commending the agency for taking swift action to ensure continuity of care for people with lupus amid ...
WASHINGTON (CBSNewYork.com/AP) The Food and Drug Administration on Wednesday approved the first new drug to treat lupus in over 50 years, a milestone that medical ...
If you can become pregnant, it’s important to consider whether Benlysta is a safe choice for you. Monoclonal antibodies, such as belimumab (the active drug in Benlysta), may affect the immune system ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback